• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2005 Fiscal Year Final Research Report Summary

Elucidation of the neurodegenerative mechanism induced by amylospheroid

Research Project

Project/Area Number 16500235
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Nerve anatomy/Neuropathology
Research InstitutionMitsubishi Kagaku Institute of Life Sciences

Principal Investigator

HOSHI Minako  Mitsubishi Kagaku Institute of Life Sciences, Research Department, Senior Researcher, 研究部門, 主任研究員 (30374010)

Project Period (FY) 2004 – 2005
Keywordsneurodegeneration / calcium / Alzheimer's disease / β-amyloid / solvent environments / self-organization
Research Abstract

Oligomerization of β-amyloid (Aβ) has been hypothesized to initiate the pathogenic cascade of Alzheimer's disease (AD). Recent studies have shown that instead of fibrils, soluble oligomers are regarded as the substance of neurotoxicity, yet the physical and biochemical features of the toxic oligomers are still unclear. Among various Aβ oligomers including fibrils, we have previously identified and purified 10-15-nm spheres as the most toxic species in vitro, which we call amylospheroid (ASPD) (Hoshi et al. PNAS 2003). Recently we obtained the data suggesting the in vivo presence of ASPD (Noguchi, A., Matsumura, S., Hoshi, M., manuscript in preparation). These results raise the possibility that ASPD or ASPD-like molecule plays a potential role in the AD process. Therefore, elucidation of the ASPD formation will contribute to clarify which environments and how they induce the formation of the toxic Aβ oligomers in AD brains as well as to AD therapeutics.
In this study, we have examined the chemical environments that promote ASPD formation and reasoned that ASPD formation is off the pathway to fibrils. It should be noted that in every conditions examined, neurotoxicity correlated solely with the formation of 10-15-nm ASPD. Furthermore, we addressed the question whether Aβ with familial mutations in its sequence, D7N-Aβ (Tottori) or E22G-Aβ (Arctic), forms ASPD as observed in the case of wild type Aβ. The neurotoxicity as well as the formation efficiency of ASPD derived from these mutants will also be presented (Noguchi, A., Hoshi, M., unpublished data). We also found that ASPD induced calcium influx in neurons which lead to calpain activation and co1comitant cell death (Kikuchi, S., Yanazawa, M., Hoshi, M., manuscript in preparation).

  • Research Products

    (5 results)

All 2006 2005

All Journal Article (4 results) Patent(Industrial Property Rights) (1 results)

  • [Journal Article] 分子の探索からシステムの解明へ-アルツハイマー病研究に想う神経科学の今後への私感2006

    • Author(s)
      星美奈子
    • Journal Title

      繊維と工業 62・1

      Pages: 17-18

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] From Molecules To Systems - A Private Opinion On Future Neuroscience2006

    • Author(s)
      Hoshi, M.
    • Journal Title

      Fiber and industry 62-1

      Pages: 17-18

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] The effect of Trehalose on the aggregation of β-amyloid2005

    • Author(s)
      Watanabe, A., Okahata, Y., Furusawa, H., Hoshi, M., Sakurai, M.
    • Journal Title

      Cryobiology and Cryotechnology 51・

      Pages: 137-140

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] The effect of Trehalose on the aggregation of β-amyloid2005

    • Author(s)
      Watanabe, A., Okahata, Y., Furusawa, H., Hoshi, M., Sakurai, M.
    • Journal Title

      Cryobiology and Cryotechnology 51

      Pages: 137-140

    • Description
      「研究成果報告書概要(欧文)」より
  • [Patent(Industrial Property Rights)] アミロスフェロイドにより発生する疾患の予防治療剤2005

    • Inventor(s)
      星 美奈子
    • Industrial Property Rights Holder
      三菱化学株式会社
    • Industrial Property Number
      特願2005-169910
    • Filing Date
      2005-06-09
    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi